ReaGene Innovations Pvt Ltd, a start-up incubated at the University of Hyderabad’s Incubation centre, ASPIRE BioNEST, has developed two diagnostic tests, Elisa and Fast Flow Spot, based on saliva samples, to detect the neutralising activity of samples in response to COVID vaccination.
After any vaccine against COVID, the body develops neutralising antibodies which help fight the virus. The degree of protection offered by the vaccine depends on the neutralising antibodies that are generated by the individual’s immune system. After some time, the neutralising antibody decreases, and booster doses may be required, said an official spokesman on Thursday.
Elisa diagnostic test can be used in a hospital or pathology lab setting that can quantitatively assess multiple samples at the same time, where as Fast Flow Spot diagnostic test is a single user test that can be used by individuals at home.
